Announcements Trials
Browse Landscape

Phase

Phase 3 3

Status

Recruiting 2Active not recruiting 1

Sponsor Class

INDUSTRY 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 63Neoplasms 5Neoplasm Metastasis 5Carcinoma, Intraductal, Noninfiltrating 3Breast Neoplasms, Male 3Recurrence 2Ovarian Neoplasms 2Endometrial Neoplasms 2Breast Diseases 2Uterine Cervical Neoplasms 1Unilateral Breast Neoplasms 1Tuberous Sclerosis 1Squamous Cell Carcinoma of Head and Neck 1Sexual Dysfunctions, Psychological 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Neuroendocrine Tumors 1Neoplasms by Site 1Multiple Endocrine Neoplasia Type 1 1Locoregional Recurrence 1Hyperglycemia 1Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer 1Hereditary Sensory and Autonomic Neuropathies 1Head and Neck Neoplasms 1HER2-positive Breast Cancer 1Granulosa cell tumor of the ovary 1Endometrial Stromal Tumors 1Endometrial Hyperplasia 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1

Interventions

Paclitaxel 4Cyclophosphamide 4exemestane 3Taxes 3Tamoxifen 3Letrozole 3Doxorubicin 3Anastrozole 3Trastuzumab 2Leuprolide 2Immunotherapy 2Goserelin 2Carboplatin 2trastuzumab biosimilar HLX02 1ribociclib 1pegfilgrastim 1elacestrant 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1abemaciclib 1Vitamins 1Standard of Care 1Radiosurgery 1Psychiatric Rehabilitation 1Practice Guidelines as Topic 1PF-05280014 1Ontruzant 1Omeprazole 1Ogivri 1Neoadjuvant Therapy 1Methods 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Breast Neoplasms, Male × exemestane × 1 year × Clear all
NCT05827081 2026-06-03

Adjuvant WIDER

Novartis

Phase 3 Recruiting
1,400 enrolled
Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT06492616 2026-05-27

ELEGANT

Stemline Therapeutics, Inc.

Phase 3 Recruiting
4,220 enrolled
Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT01674140 2026-02-10

e3

SWOG Cancer Research Network

Phase 3 Active not recruiting
1,939 enrolled 15 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡